Overview
Justin May is a litigation and regulatory attorney who advises companies facing complex legal risk at the intersection of courtroom disputes, government regulation, and business operations. His practice centers on regulatory‑driven commercial litigation and enforcement‑adjacent matters, particularly within highly regulated and emerging industries. Justin brings a pragmatic, business‑focused approach to disputes that implicate regulatory compliance, product risk, and public‑facing exposure.
Justin regularly represents and counsels companies in matters involving product liability, consumer protection, insurance coverage, and government investigations, with a particular focus on dietary supplements, botanicals, functional ingredients, and novel consumer products. He helps clients navigate state and federal regulatory regimes, develop pre‑enforcement strategies, and defend against private litigation and regulatory actions, often counseling clients well before issues mature into disputes. His work frequently involves labeling and marketing review, regulatory risk assessments, and coordination with specialized regulatory and scientific advisors.
In addition to active litigation and regulatory defense, Justin serves as strategic outside counsel to growth‑stage and middle‑market companies, assisting with contract drafting, governance matters, and transaction‑adjacent risk management. He is routinely engaged to negotiate and structure agreements that are likely to be tested under regulatory or litigation pressure and works closely with corporate and regulatory colleagues to deliver integrated legal solutions. Clients value Justin’s ability to combine litigation instincts with practical, forward‑looking advice that aligns legal risk management with business objectives.
Experience
Solutions in action
- Represented client before high profile congressional oversight committee.
- Performed internal investigation for client at center of national controversy arising from actions of executive officer.
- Represent veterinary product manufacturer against federal regulators for alleged violations of FFDCA.
- Represented business owners in shareholder and operating agreement disputes.
- Represented international electronic health records company in response and investigations into multiple data incidents.
- Represented hospital in dispute over eight-figure CMS / Medicare recoupment action.
- Represented health care provider in administrative litigation arising from allegations of overbilling Medicaid by seven figures.
- Represented health care provider in recoupment and administrative litigation arising from allegations of overbilling Medicaid by six figures.
- Represented health care providers in professional disciplinary proceedings.
- Represented employers in matters arising from alleged breaches restrictive covenants and trade secret agreements.
- Represented employers in internal investigations and litigation arising out of employee misconduct, including fraud, embezzlement, and sexual misconduct.
Credentials
- Wake Forest University School of Law, Juris Doctor (J.D.), 2014
- The University of Texas at Austin, Bachelor of Arts (B.A.), 2011
- North Carolina
- United States District Court, Eastern District of North Carolina
- United States District Court, Middle District of North Carolina
- United States District Court, Western District of North Carolina
- United States Court of Appeals, Fourth Circuit
- Selected to Business Litigation, Administrative Law, Civil Litigation Rising Stars, Super Lawyers®, 2023-Present
Engagement
- Michael Best Summer Associate Co-Chair, 2023
- Holy Name of Jesus Cathedral, Finance Council Member
- North Carolina Bach Festival, Former Board of Director Member
- American Health Lawyers Association, Member
- American Bar Association, Member
- North Carolina Bar Association, Member
Insights

From Secret Tests to Therapy Trials: MDMA’s Long Road to Legitimacy
First synthesized in 1912, MDMA’s history is long and varied. In the 1940s, the U.S. Army conducted classified MDMA tests as part of its chemical warfare research program, while the 1970s saw it being introduced to psychotherapy.[1] The drug’s success among patients—reducing their fear response and facilitating emotional breakthroughs—led to increased recreational use in the 1980s.Read
Mar 12, 2025

Federal Appellate Court Overturns Trial Court in Favor of Religious Private School Due to Constitutional Ministerial Exception
The U.S. Court of Appeals for the Fourth Circuit issued an opinion on May 8, 2024 affirming the right of a religious school to part…Read
Jun 3, 2024
